News

NEWS

Company News

Home page

2016

Published Time:

2016-07-07

Author:

Source:

Abstract

Realbio-Technology Company was established with a registered capital of 110 million
Shenzhen Realbio Group Co., Ltd. was established
Realbio was awarded the High-Tech Enterprise Certificate;
Chairman Su Shaobo was elected as a standing committee member of the First Committee of the Immunoassay Professional Committee of the Chinese Society for Analytical Testing;
Realbio completed the accumulation of protein purification and multi-antibody immunization related technology verification, and obtained a number of related patents

Realbio was established with a registered capital of 110 million
Shenzhen Realbio Group Co., Ltd. was established
Realbio received the High-tech Enterprise Certificate; Chairman Su Shaobo was elected as a member of the Standing Committee of the First Committee of the Immunoassay Professional Committee of the Chinese Society for Analytical Testing;
Realbio completed the accumulation of technology verification related to protein purification and multi-antigen immunization, and obtained a number of related patents

Keywords:

IVD Raw Materials | Biological Products

September 2017

2015

HOT NEWS

ADLM 2026 | Connecting Global IVD Innovation, Exploring New Paradigms in IVD

As one of the most influential industry events in the field of laboratory medicine worldwide, ADLM 2026 (Association for Diagnostics & Laboratory Medicine) will be held from July 26–30, 2026, in Anaheim, California, USA. It is expected to bring together diagnostic companies, research institutions, clinical laboratories, and industry chain partners from over 100 countries to showcase the latest technologies and innovative achievements in laboratory medicine and in vitro diagnostics. Each year, ADLM attracts hundreds of exhibiting companies and covers a broad spectrum of areas including molecular diagnostics, immunoassays, clinical chemistry, POCT, mass spectrometry, and digital laboratories, making it a vital exchange platform for the global IVD industry.

2026-07-14

Realbio and Thermo Fisher have entered into a strategic partnership to co-build a new ecosystem for localized IVD quality control services.

On May 12, the strategic signing ceremony between Realbio and Thermo Fisher Scientific, a global leader in scientific services, was successfully held at the Thermo Fisher Customer Experience Center in Shanghai. The two parties will engage in in-depth collaboration on "integrated solutions for in-vitro diagnostic quality control materials," jointly embarking on a new chapter of resource sharing and value co-creation. Attendees at the signing ceremony included Patrick Jones, Global President of Professional Diagnostics at Thermo Fisher; Anuj Dhingra, Global Vice President of Professional Diagnostics; Linda Tang, Commercial Director of Professional Diagnostics, China; Luca Saronni, Global Chief Business Development Manager of Clinical Diagnostics; Liangchao Huang, Senior Sales Manager of Clinical Diagnostics, China; Anita Zhang, Product Specialist of Clinical Diagnostics Marketing, China; as well as Su Shaobo, Chairman of Shenzhen Realbio Group; Jiang Wenyu, Deputy General Manager of Operations; and Ji Hongyu, International Business Development Manager. This signing represents not only a joining of hands between the two enterprises but also another significant milestone for Ruiyali in enhancing its local industrial translation capabilities.

2026-05-12

Guangdong Provincial Engineering Technology Research Center for IVD Core Raw Materials (Realbio) Inauguration & Cooperation Signing Ceremony between Shenzhen Realbio Group and Shenzhen CDC

On April 9, Realbio Group and the Shenzhen CDC officially signed a strategic cooperation agreement in Shenzhen. The two parties will engage in in-depth collaboration on the construction of a clinical translation evaluation system for in-vitro diagnostics (IVD), with the aim of bridging the "last mile" from the laboratory to clinical application, enhancing the industry's regulatory market access capabilities, and contributing to the development of a public service platform for the diagnostics field in the Greater Bay Area.

2026-04-10

86 755-36560632

+86 13530508971

market@realbiogroup.com

Headquarters address: Building 1, Shenfubao Science and Technology Ecological Industrial Park, No. 18 Jinxiu West Road, Pingshan District, Shenzhen

City Substation

Business License

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Message

8613026671026

market@realbiogroup.com

+86 0755-4959330

搜索历史清除全部记录

最多显示8条历史搜索记录噢~

All

All
Product Management
News
Introduction
Corporate Outlets
FAQ
Corporate Video
Corporate Brochure